Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.
about
Animal models of α-synucleinopathy for Parkinson disease drug development.Monosialoganglioside 1 may alleviate neurotoxicity induced by propofol combined with remifentanil in neural stem cells.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.Sphingomyelin and GM1 Influence Huntingtin Binding to, Disruption of, and Aggregation on Lipid Membranes.
P2860
Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@ast
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@en
type
label
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@ast
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@en
prefLabel
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@ast
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@en
P2093
P2860
P1433
P1476
Intraventricular Sialidase Adm ...... Model of Parkinson's Disease.
@en
P2093
Hyo-S Choi
Jay S Schneider
Sarah K Kidd
P2860
P304
P356
10.1371/JOURNAL.PONE.0143351
P407
P577
2015-12-02T00:00:00Z